Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,206 articles, preprints and more)

Suggested authors matching "AUTH:Lidbrink E" with an ORCID

Elisabet Lidbrink
Karolinska Universitetssjukhuset
1
Publication
19
Citations
View profile

Search results

1-25 of 49 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study.
Hall KS, Bruland ØS, Bjerkehagen B, Lidbrink E, Jebsen N, Hagberg H, Papworth K, Hagberg O, Trovik C, Bauer H, Eriksson M
Clin Sarcoma Res, 10(1):22, 17 Nov 2020
Cited by: 1 article | PMID: 33292545 | PMCID: PMC7672981
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C
Menopause, 27(5):526-534, 01 May 2020
Cited by: 14 articles | PMID: 32049923 | PMCID: PMC7188038
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.
Brodin BA, Wennerberg K, Lidbrink E, Brosjö O, Potdar S, Wilson JN, Ma L, Moens LN, Hesla A, Porovic E, Bernhardsson E, Papakonstantinou A, Bauer H, Tsagkozis P, von Sivers K, Wejde J, Östling P, Kallioniemi O, Stragliotto CL
Br J Cancer, 120(4):435-443, 12 Feb 2019
Cited by: 20 articles | PMID: 30745580 | PMCID: PMC6462037
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A real-world study of cardiac events in > 3700 patients with HER2-positive early breast cancer treated with trastuzumab: final analysis of the OHERA study.
Lidbrink E, Chmielowska E, Otremba B, Bouhlel A, Lauer S, Liste Hermoso M, Nüesch E, Shing M, Misra V
Breast Cancer Res Treat, 174(1):187-196, 30 Nov 2018
Cited by: 19 articles | PMID: 30506110 | PMCID: PMC6418299
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G, Ekberg S, Lidbrink E, Eloranta S, Sund M, Fredriksson I, Lambe M, Smedby KE
Breast Cancer Res, 20(1):142, 20 Nov 2018
Cited by: 18 articles | PMID: 30458873 | PMCID: PMC6247765
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
Matikas A, Margolin S, Hellström M, Johansson H, Bengtsson NO, Karlsson L, Edlund P, Karlsson P, Lidbrink E, Linderholm B, Lindman H, Malmstrom P, Villman K, Foukakis T, Bergh J
Breast Cancer Res Treat, 168(2):349-355, 30 Nov 2017
Cited by: 4 articles | PMID: 29190004 | PMCID: PMC5838137
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer.
Sarhan D, Leijonhufvud C, Murray S, Witt K, Seitz C, Wallerius M, Xie H, Ullén A, Harmenberg U, Lidbrink E, Rolny C, Andersson J, Lundqvist A
Oncoimmunology, 6(8):e1338238, 14 Jun 2017
Cited by: 12 articles | PMID: 28920001 | PMCID: PMC5593706
Add to export list Free full text in Europe PMC
Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy.
Frisk G, Tinge B, Ekberg S, Eloranta S, Bäcklund LM, Lidbrink E, Smedby KE
Breast Cancer Res Treat, 166(3):887-896, 22 Aug 2017
Cited by: 11 articles | PMID: 28831636 | PMCID: PMC5680371
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The effect of radiotherapy on fat content and fatty acids in myxoid liposarcomas quantified by MRI.
Skorpil M, Rydén H, Wejde J, Lidbrink E, Brosjö O, Berglund J
Magn Reson Imaging, 43:37-41, 08 Jul 2017
Cited by: 4 articles | PMID: 28698004
Add to export list
Transcriptional Profiling of Breast Cancer Metastases Identifies Liver Metastasis-Selective Genes Associated with Adverse Outcome in Luminal A Primary Breast Cancer.
Kimbung S, Johansson I, Danielsson A, Veerla S, Egyhazi Brage S, Frostvik Stolt M, Skoog L, Carlsson L, Einbeigi Z, Lidbrink E, Linderholm B, Loman N, Malmström PO, Söderberg M, Walz TM, Fernö M, Hatschek T, Hedenfalk I, TEX study group
Clin Cancer Res, 22(1):146-157, 14 Aug 2015
Cited by: 28 articles | PMID: 26276891
Add to export list
Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival.
Tobin NP, Harrell JC, Lövrot J, Egyhazi Brage S, Frostvik Stolt M, Carlsson L, Einbeigi Z, Linderholm B, Loman N, Malmberg M, Walz T, Fernö M, Perou CM, Bergh J, Hatschek T, Lindström LS, TEX Trialists Group
Ann Oncol, 26(1):81-88, 31 Oct 2014
Cited by: 58 articles | PMID: 25361981 | PMCID: PMC4269343
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, [...] Austrian Breast and Colorectal Cancer Study Group
Lancet, 386(9992):433-443, 31 May 2015
Cited by: 228 articles | PMID: 26040499
Add to export list
Radiation-induced changes in levels of selected proteins in peripheral blood serum of breast cancer patients as a potential triage biodosimeter for large-scale radiological emergencies.
Deperas-Kaminska M, Bajinskis A, Marczyk M, Polanska J, Wersäll P, Lidbrink E, Ainsbury EA, Guipaud O, Benderitter M, Haghdoost S, Wojcik A
Health Phys, 107(6):555-563, 01 Dec 2014
Cited by: 7 articles | PMID: 25353241
Add to export list
Unique proteomic signature for radiation sensitive patients; a comparative study between normo-sensitive and radiation sensitive breast cancer patients.
Skiöld S, Azimzadeh O, Merl-Pham J, Naslund I, Wersall P, Lidbrink E, Tapio S, Harms-Ringdahl M, Haghdoost S
Mutat Res, 776:128-135, 18 Dec 2014
Cited by: 11 articles | PMID: 26255944
Add to export list
[Free of charge mammography gets more people to the examination. Study in Stockholm County shows good efficacy in socioeconomically disadvantaged areas].
Törnberg S, Lidbrink E, Henriksson R
Lakartidningen, 111(7):278-281, 01 Feb 2014
Cited by: 3 articles | PMID: 24669490
Add to export list
Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.
Linderholm BK, Lidbrink E, Tallroth E, Einbeigi Z, Svensson H, von Wachenfeldt A, Norberg B, Carlsson L, Olsson ME, Bergh J, Wilking N, Hatschek T
Breast, 22(6):1142-1147, 20 Aug 2013
Cited by: 3 articles | PMID: 23968864
Add to export list
Radiation-induced stress response in peripheral blood of breast cancer patients differs between patients with severe acute skin reactions and patients with no side effects to radiotherapy.
Skiöld S, Naslund I, Brehwens K, Andersson A, Wersall P, Lidbrink E, Harms-Ringdahl M, Wojcik A, Haghdoost S
Mutat Res, 756(1-2):152-157, 04 May 2013
Cited by: 13 articles | PMID: 23652022
Add to export list
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer.
Bergh J, Jönsson PE, Lidbrink EK, Trudeau M, Eiermann W, Brattström D, Lindemann JP, Wiklund F, Henriksson R
J Clin Oncol, 30(16):1919-1925, 27 Feb 2012
Cited by: 148 articles | PMID: 22370325
Add to export list
Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression.
Lindström LS, Karlsson E, Wilking UM, Johansson U, Hartman J, Lidbrink EK, Hatschek T, Skoog L, Bergh J
J Clin Oncol, 30(21):2601-2608, 18 Jun 2012
Cited by: 290 articles | PMID: 22711854
Add to export list
Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden.
Frisk G, Svensson T, Bäcklund LM, Lidbrink E, Blomqvist P, Smedby KE
Br J Cancer, 106(11):1850-1853, 24 Apr 2012
Cited by: 64 articles | PMID: 22531629 | PMCID: PMC3364124
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial.
Hatschek T, Carlsson L, Einbeigi Z, Lidbrink E, Linderholm B, Lindh B, Loman N, Malmberg M, Rotstein S, Söderberg M, Sundquist M, Walz TM, Hellström M, Svensson H, Aström G, Brandberg Y, Carstensen J, Fernö M, Bergh J
Breast Cancer Res Treat, 131(3):939-947, 18 Nov 2011
Cited by: 19 articles | PMID: 22094937
Add to export list
Phase III randomized study comparing docetaxel plus trastuzumab with vinorelbine plus trastuzumab as first-line therapy of metastatic or locally advanced human epidermal growth factor receptor 2-positive breast cancer: the HERNATA study.
Andersson M, Lidbrink E, Bjerre K, Wist E, Enevoldsen K, Jensen AB, Karlsson P, Tange UB, Sørensen PG, Møller S, Bergh J, Langkjer ST
J Clin Oncol, 29(3):264-271, 13 Dec 2010
Cited by: 154 articles | PMID: 21149659
Add to export list
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study.
Eriksen C, Frisell J, Wickman M, Lidbrink E, Krawiec K, Sandelin K
Breast Cancer Res Treat, 127(2):439-446, 16 Mar 2011
Cited by: 49 articles | PMID: 21409394
Add to export list
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Bonnefoi H, Piccart M, Bogaerts J, Mauriac L, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Blot E, Zaman K, Cufer T, Lortholary A, Lidbrink E, André S, Litière S, Lago LD, Becette V, Cameron DA, [...] EORTC 10994/BIG 1-00 Study Investigators
Lancet Oncol, 12(6):527-539, 11 May 2011
Cited by: 82 articles | PMID: 21570352 | PMCID: PMC4172919
Add to export list Free full text in Europe PMC
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression.
Wilking U, Karlsson E, Skoog L, Hatschek T, Lidbrink E, Elmberger G, Johansson H, Lindström L, Bergh J
Breast Cancer Res Treat, 125(2):553-561, 14 Jul 2010
Cited by: 66 articles | PMID: 20628810
Add to export list

1-25 of 49 results

1 2

Search life-sciences literature (45,104,206 articles, preprints and more)

Suggested authors matching "AUTH:Lidbrink E" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:Lidbrink E" with an ORCID